Daniel J. Brennan
Net Worth

Last updated:

What is Daniel J. Brennan net worth?

The estimated net worth of Mr. Daniel J. Brennan is at least $43,904,046 as of 22 May 2024. He owns shares worth $23,486,075 as insider, has earned $14,177,971 from insider trading and has received compensation worth at least $6,240,000 in Boston Scientific Corporation.

What is the salary of Daniel J. Brennan?

Mr. Daniel J. Brennan salary is $1,040,000 per year as Executive Vice President & Chief Financial Officer in Boston Scientific Corporation.

How old is Daniel J. Brennan?

Mr. Daniel J. Brennan is 59 years old, born in 1966.

What stocks does Daniel J. Brennan currently own?

As insider, Mr. Daniel J. Brennan owns shares in one company:

Company Title Shares Price per share Total value
Boston Scientific Corporation (BSX) Executive Vice President & Chief Financial Officer 225,958 $103.94 $23,486,075

What does Boston Scientific Corporation do?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX logo
BSX
Boston Scientific Corporation
$103.94

Daniel J. Brennan insider trading

Boston Scientific Corporation

Mr. Daniel J. Brennan has made 14 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 75,610 units of BSX stock on 1 Mar 2023. As of 22 May 2024 he still owns at least 225,958 units of BSX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 15,086 $16.31 $246,053
Option
Common Stock 16,863 $17.26 $291,055
Option
Common Stock 15,642 $27.09 $423,742
Option
Performance Share Units 23,979 N/A N/A
Option
Common Stock 23,979 N/A N/A
Sale
Common Stock 30,000 $46.66 $1,399,920
Option
Stock Option (Right to Buy) 15,086 $16.31 $246,053
Option
Common Stock 16,863 $17.26 $291,055
Option
Common Stock 15,086 $16.31 $246,053
Sale
Common Stock 75,610 $46.64 $3,526,375
Option
Common Stock 13,661 $13.08 $178,686
Option
Stock Option (Right to Buy) 13,661 $13.08 $178,686
Option
Stock Option (Right to Buy) 16,863 $17.26 $291,055
Option
Common Stock 3,661 N/A N/A
Option
Deferred Stock Units 3,661 N/A N/A
Sale
Common Stock 11,029 $44.03 $485,651
Sale
Common Stock 53,182 $42.75 $2,273,637
Option
Common Stock 13,661 $13.08 $178,686
Option
Common Stock 7,572 $7.39 $55,957
Option
Common Stock 15,086 $16.31 $246,053
Option
Common Stock 16,863 $17.26 $291,055
Option
Stock Option (Right to Buy) 16,863 $17.26 $291,055
Option
Stock Option (Right to Buy) 15,086 $16.31 $246,053
Option
Stock Option (Right to Buy) 13,661 $13.08 $178,686
Option
Stock Option (Right to Buy) 7,572 $7.39 $55,957
Option
Common Stock 3,661 N/A N/A
Option
Deferred Stock Units 3,661 N/A N/A
Sale
Common Stock 12,187 $43.7 $532,584
Option
Deferred Stock Units 4,153 N/A N/A
Option
Stock Option (Right to Buy) 12,187 $6.28 $76,534
Option
Common Stock 12,187 $6.28 $76,534
Option
Common Stock 4,153 N/A N/A
Sale
Common Stock 9,136 $43.47 $397,142
Option
Performance Share Units 13,193 N/A N/A
Option
Common Stock 13,193 N/A N/A
Sale
Common Stock 12,127 N/A N/A
Sale
Common Stock 9,475 N/A N/A
Option
Common Stock 4,481 N/A N/A
Option
Deferred Stock Units 4,481 N/A N/A
Sale
Common Stock 24,846 $7.16 $177,897
Option
Common Stock 24,846 $7.16 $177,897
Option
Stock Option (Right to Buy) 24,846 $7.16 $177,897
Option
Common Stock 5,794 N/A N/A
Option
Deferred Stock Units 5,794 N/A N/A
Option
Deferred Stock Units 3,661 N/A N/A
Option
Common Stock 3,661 N/A N/A
Option
Deferred Stock Units 3,706 N/A N/A
Option
Common Stock 3,706 N/A N/A
Option
Common Stock 4,153 N/A N/A
Option
Deferred Stock Units 4,153 N/A N/A
Sale
Common Stock 17,083 $35.32 $603,406
Option
Performance Share Units 24,479 N/A N/A
Option
Common Stock 24,479 N/A N/A
Option
Deferred Stock Units 4,481 N/A N/A
Option
Common Stock 4,481 N/A N/A
Option
Deferred Stock Units 5,365 N/A N/A
Option
Common Stock 5,365 N/A N/A
Option
Deferred Stock Units 5,794 N/A N/A
Option
Common Stock 5,794 N/A N/A
Option
Common Stock 3,660 N/A N/A
Option
Deferred Stock Units 3,660 N/A N/A
Option
Deferred Stock Units 4,153 N/A N/A
Option
Common Stock 4,153 N/A N/A
Option
Common Stock 20,463 $7.41 $151,631
Option
Stock Option (Right to Buy) 20,463 $7.41 $151,631
Sale
Common Stock 20,463 $7.41 $151,631
Option
Common Stock 21,865 N/A N/A
Option
Performance Share Units 21,865 N/A N/A
Option
Common Stock 20,462 $7.41 $151,623
Option
Stock Option (Right to Buy) 20,462 $7.41 $151,623
Sale
Common Stock 20,462 $7.41 $151,623
Sale
Common Stock 46,360 $40.03 $1,855,559
Sale
Common Stock 64,223 $40.84 $2,622,546